Bailard adds Stryker Corporation (SYK) to its portfolio

Stryker Corporation (SYK) : Bailard added new position in Stryker Corporation during the most recent quarter end. The investment management firm now holds 23,730 shares of Stryker Corporation which is valued at $2,741,527 , the company said in a statement filed on Aug 8, 2016 with the SEC.Stryker Corporation makes up approximately 0.32% of Bailard’s portfolio.

Other Hedge Funds, Including , Ashfield Capital Partners reduced its stake in SYK by selling 351 shares or 1.12% in the most recent quarter. The Hedge Fund company now holds 30,863 shares of SYK which is valued at $3,565,602. Stryker Corporation makes up approx 0.27% of Ashfield Capital Partners’s portfolio.Tdam Usa reduced its stake in SYK by selling 1,425 shares or 1.81% in the most recent quarter. The Hedge Fund company now holds 77,278 shares of SYK which is valued at $8,879,242. Stryker Corporation makes up approx 0.42% of Tdam Usa’s portfolio.

Stryker Corporation closed down -0.34 points or -0.29% at $115.23 with 5,68,638 shares getting traded on Monday. Post opening the session at $115.5, the shares hit an intraday low of $115.23 and an intraday high of $115.8 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.